
Bharat Biotech has signed up 13,000 volunteers for the Phase 3 trial, backed by India's government medical research body, and is progressing towards its goal of 26,000, the company said. The trial began in mid-November at multiple sites across India.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37CUi1a
via
IFTTT
0 comments:
Post a Comment